Key Takeaways
- Eurozone unemployment fell to a record low of 6.2% in May, outperforming market expectations of 6.3% and signaling continued labor market resilience despite broader economic headwinds.
- Standard Chartered projected China's Q2 GDP growth to slow to 4.3% year-over-year, citing a significant downturn in fiscal spending and a persistent slump in the property sector.
- Abivax (ABVX) shares surged as the biotech firm secured $920 million in gross proceeds through an upsized share offering, providing a cash runway through 2029 for its lead drug candidate, obefazimod.
- The "Trump Accounts" children's investment program is set to launch July 4 without rollover options, forcing initial participants to use the Treasury's official app rather than private platforms like SoFi (SOFI) or Fidelity.
- Japan and Saudi Arabia reached a critical energy security agreement to utilize the Red Sea as an alternative oil supply route, bypassing the volatile Strait of Hormuz amid ongoing regional tensions.
Eurozone Labor Market Hits Historic Milestone
The Eurozone unemployment rate reached a record low of 6.2% in May 2024, according to data released by Eurostat. This figure came in slightly better than the 6.3% anticipated by economists and represents a decrease from the revised 6.3% recorded in April.
While major economies like Germany (3.8%) and the Netherlands (3.9%) maintained low jobless rates, southern European nations continued to see improvements. However, analysts at MUFG Research noted that softer inflation data accompanying these figures may dampen the European Central Bank's appetite for further interest rate hikes later this year.
China's Recovery Stumbles on Fiscal Drag
Standard Chartered has warned that China's second-quarter GDP growth likely slowed to 4.3%, a notable deceleration from the stronger-than-expected 5.3% expansion seen in the first quarter. The bank pointed to a CNY 393 billion contraction in the broad fiscal deficit during April and May as a primary driver for the weakening momentum.
Despite the slowdown, economists expect Beijing to accelerate budget implementation in the second half of the year. Standard Chartered maintained its full-year 2026 growth forecast at 4.6%, betting on a rebound in domestic demand and continued strength in high-tech manufacturing exports.
Biotech and Industrial Market Moves
In the healthcare sector, Abivax (ABVX) saw its valuation climb toward $11 billion after underwriters fully exercised options in a massive capital raise. The total haul of $920 million is earmarked for the Phase 3 clinical trials and potential U.S. commercialization of obefazimod, a treatment for ulcerative colitis.
Conversely, Siemens (SIE) faced pressure as BofA Global Research slashed its price objective for the industrial giant to EUR 48 from EUR 60. The downgrade reflects broader concerns regarding industrial demand cycles and capital expenditure trends across the European manufacturing landscape.
Federal Policy and Geopolitical Shifts
The U.S. Treasury is preparing for the July 4 launch of Trump Accounts, a tax-advantaged savings program offering $1,000 in seed money for eligible children. However, a report from Semafor indicates that private fintech firms like Robinhood (HOOD) and Chime will not be able to host rollover accounts at launch, potentially slowing initial adoption.
On the geopolitical front, Japan and Saudi Arabia have finalized plans to secure energy flows via the Red Sea. This strategic shift follows the effective closure of the Strait of Hormuz earlier this year, which at its peak disrupted nearly 20% of global oil trade. The agreement ensures Japan can meet domestic demand through 2026 without incurring the "extra costs" associated with high-risk maritime corridors.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.